Johannes Stein

677 total citations
33 papers, 467 citations indexed

About

Johannes Stein is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Johannes Stein has authored 33 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Johannes Stein's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urological Disorders and Treatments (4 papers). Johannes Stein is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urological Disorders and Treatments (4 papers). Johannes Stein collaborates with scholars based in Germany, Austria and United States. Johannes Stein's co-authors include Glen Kristiansen, Jörg Ellinger, Michael Majores, Dimo Dietrich, Heidrun Gevensleben, Maria Jung, Klaus Jung, Carsten Stephan, Barbara Uhl and Stefan C. Müller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Johannes Stein

28 papers receiving 460 citations

Peers

Johannes Stein
Johannes Stein
Citations per year, relative to Johannes Stein Johannes Stein (= 1×) peers Kuo-Pao Lai

Countries citing papers authored by Johannes Stein

Since Specialization
Citations

This map shows the geographic impact of Johannes Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Stein more than expected).

Fields of papers citing papers by Johannes Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Stein. The network helps show where Johannes Stein may publish in the future.

Co-authorship network of co-authors of Johannes Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Stein. A scholar is included among the top collaborators of Johannes Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Stein. Johannes Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krausewitz, Philipp, Thomas Büttner, Niklas Klümper, et al.. (2024). Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center. BMC Urology. 24(1). 71–71. 1 indexed citations
2.
Klümper, Niklas, Markus Eckstein, Christoph Kuppe, et al.. (2024). High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma. European Journal of Cancer. 204. 114089–114089. 4 indexed citations
3.
Siener, Roswitha, Johannes Stein, & Manuel Ritter. (2024). Rezidivprävention der Urolithiasis. PubMed. 63(4). 387–395.
4.
Büttner, Thomas, Jörg Ellinger, G. Fechner, et al.. (2024). Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy. Urology Case Reports. 53. 102675–102675.
5.
Stein, Johannes, Marcus V. Cronauer, Markus Essler, et al.. (2024). Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer. Journal of Cancer Research and Clinical Oncology. 150(2). 76–76. 1 indexed citations
6.
Ellinger, Jörg, et al.. (2024). Urology consultants versus large language models: Potentials and hazards for medical advice in urology. SHILAP Revista de lepidopterología. 5(5). 552–558. 6 indexed citations
7.
Klümper, Niklas, Philipp Krausewitz, Abdullah Alajati, et al.. (2023). Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers. Cancers. 15(6). 1890–1890. 3 indexed citations
8.
Büttner, Thomas, et al.. (2023). Psoas abscess in pregnancy: a review of the literature and suggestion of minimally invasive treatment options. Archives of Gynecology and Obstetrics. 309(3). 987–992. 2 indexed citations
9.
Klümper, Niklas, Johannes Stein, Danijel Sikic, et al.. (2023). Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. European Urology. 85(4). 328–332. 4 indexed citations
10.
Stein, Johannes, et al.. (2022). Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis. Biomedicines. 10(12). 3260–3260. 8 indexed citations
11.
Krausewitz, Philipp, Johannes Stein, Julian A. Luetkens, et al.. (2022). Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study. World Journal of Urology. 41(1). 19–25. 11 indexed citations
12.
Stein, Johannes, et al.. (2021). Evolution of AquablationVR—From innovation to establishment. SHILAP Revista de lepidopterología. 47(5). 351–357. 2 indexed citations
13.
Bufe, Alexander, et al.. (2018). Acute, in-Hospital Outcome of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion. Cardiovascular revascularization medicine. 20(11). 997–1000. 3 indexed citations
14.
Stein, Johannes & Max Geraedts. (2017). Beigebrauchdetektion in der Substitutionstherapie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 60(11). 1261–1268. 1 indexed citations
15.
Uhl, Barbara, Heidrun Gevensleben, Yuri Tolkach, et al.. (2016). PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies. Journal of Molecular Diagnostics. 19(1). 107–114. 38 indexed citations
16.
Stein, Johannes, Jörg Ellinger, Stefan Hauser, et al.. (2016). Primary Urethral Plasmacytoma Treated with High-Dose-Rate Brachytherapy: A Case Report. Urologia Internationalis. 97(3). 369–372.
17.
Gevensleben, Heidrun, Dimo Dietrich, Carsten Golletz, et al.. (2015). The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer. Clinical Cancer Research. 22(8). 1969–1977. 167 indexed citations
18.
Majores, Michael, Ângela Fuchs, Johannes Stein, et al.. (2015). Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients. BMC Clinical Pathology. 15(1). 19–19. 16 indexed citations
19.
Stein, Johannes, Michael Majores, Soyoung Lim, et al.. (2014). KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy. American Journal Of Pathology. 184(9). 2430–2437. 63 indexed citations
20.
Stein, Johannes, et al.. (1985). Zur Herstellung von 1,3,4‐ Oxadiazol‐2‐carbonsäurederivaten. Journal für praktische Chemie. 327(1). 109–116. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026